Oncocyte(OCX) - 2024 Q2 - Earnings Call Transcript
OncoCyte Corporation (NASDAQ:OCX) Q2 2024 Results Conference Call August 8, 2024 5:00 PM ET Company Participants Jeff Ramson - PCG Advisory Josh Riggs - Chief Executive Officer Andrea James - Chief Financial Officer Ekke Schutz - Chief Scientific Officer Conference Call Participants Joseph Conway - Needham Vidyun Bais - BTIG Operator Thank you for standing by. My name is Rochelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the OncoCyte Second Quarter 2024 ...